Tilray Inc (TLRY) - Total Liabilities

Latest as of February 2026: CA$549.12 Million CAD ≈ $397.22 Million USD

Based on the latest financial reports, Tilray Inc (TLRY) has total liabilities worth CA$549.12 Million CAD (≈ $397.22 Million USD) as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tilray Inc - Total Liabilities Trend (2012–2025)

This chart illustrates how Tilray Inc's total liabilities have evolved over time, based on quarterly financial data. See Tilray Inc (TLRY) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Tilray Inc Competitors by Total Liabilities

The table below lists competitors of Tilray Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Zhejiang Dafeng Industrial Co Ltd SHG:603081	China	CN¥4.84 Billion
Prime Medicine, Inc. Common Stock NASDAQ:PRME	USA	$218.03 Million
Jensen-Group NV BR:JEN	Belgium	€194.66 Million
Zhejiang Fuchunjiang Environmental Thermoelectric Co Ltd SHE:002479	China	CN¥3.87 Billion
Hangzhou Chinastars Reflective Material Co.Ltd. SHE:301077	China	CN¥682.93 Million
Cheng Uei Precision Industry Co Ltd TW:2392	Taiwan	NT$95.67 Billion
Sayona Mining Ltd AU:SYA	Australia	AU$177.27 Million
Mutares SE & Co. KGaA XETRA:MUX	Germany	€4.33 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Tilray Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tilray Inc (TLRY) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tilray Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tilray Inc (2012–2025)

The table below shows the annual total liabilities of Tilray Inc from 2012 to 2025.

Year	Total Liabilities	Change
2025-05-31	CA$584.75 Million ≈ $423.00 Million	-24.89%
2024-05-31	CA$778.49 Million ≈ $563.15 Million	-20.34%
2023-05-31	CA$977.32 Million ≈ $706.98 Million	-3.08%
2022-05-31	CA$1.01 Billion ≈ $729.41 Million	-35.37%
2021-05-31	CA$1.56 Billion ≈ $1.13 Billion	+227.82%
2020-05-31	CA$475.89 Million ≈ $344.25 Million	-9.11%
2019-05-31	CA$523.61 Million ≈ $378.77 Million	+380.55%
2018-05-31	CA$108.96 Million ≈ $78.82 Million	+248.65%
2017-05-31	CA$31.25 Million ≈ $22.61 Million	+3118.36%
2016-05-31	CA$971.04K ≈ $702.44K	+27.40%
2015-05-31	CA$762.17K ≈ $551.35K	+7204.72%
2014-05-31	CA$10.43K ≈ $7.55K	0.00%
2013-05-31	CA$10.43K ≈ $7.55K	-5.80%
2012-05-31	CA$11.08K ≈ $8.01K	--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic

Market Cap

$579.68 Million

CA$801.35 Million CAD

Market Cap Rank

#11631 Global

#339 in Canada

Share Price

CA$6.70

Change (1 day)

-0.59%

52-Week Range

CA$0.50 - CA$19.12

All Time High

CA$26.00